EARLY SCHIZOPHRENIA PATIENTS TREATED WITH ONCE-MONTHLY PALIPERIDONE PALMITATE OVER A 12-MONTH PERIOD - A RETROSPECTIVE OBSERVATIONAL STUDY

被引：0
|
作者：
Schreiner, A. [1 ]
Bergmans, P. [2 ]
Cherubin, P. [3 ]
Hargarter, L. [1 ]
机构：
[1] Janssen Cilag, EMEA Med Affairs, Neuss, Germany
[2] Janssen Cilag Benelux, Biostat & Programming, Tilburg, Netherlands
[3] Janssen Cilag, EMEA Med Affairs, Issy Les Moulineaux, France
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2017年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [31] Effect of time to treatment initiation with once-monthly paliperidone palmitate in hospitalised Asian patients with acute exacerbated schizophrenia
    Li, H.
    Li, Y.
    Feng, Y.
    Zhuo, J.
    Turkoz, I.
    Mathews, M.
    Tan, W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S943 - S943
  • [32] A PRAGMATIC ANALYSIS COMPARING ONCE-MONTHLY PALIPERIDONE PALMITATE VERSUS DAILY ORAL ANTIPSYCHOTIC TREATMENT IN PATIENTS WITH SCHIZOPHRENIA
    Starr, H. L.
    Bossie, C.
    Benson, C.
    Mao, Lian
    Alphs, L.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S334 - S334
  • [33] A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia
    Alphs, Larry
    Mao, Lian
    Starr, H. Lynn
    Benson, Carmela
    SCHIZOPHRENIA RESEARCH, 2016, 170 (2-3) : 259 - 264
  • [34] Treatment response and tolerability with once-monthly paliperidone palmitate initiated shortly after hospital admission in patients with schizophrenia
    Hargarter, Ludger
    Lahaye, Marjolein
    Cherubin, Pierre
    Lambert, Martin
    Swarz, Marnina
    Joldygulov, Gali
    Vischia, Flavio
    Chomskaya, Veronica
    Bozikas, Vasilis P.
    Tsapakis, Eva-Maria
    Schreiner, Andreas
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2018, 19 : S147 - S157
  • [35] FUNCTIONAL OUTCOMES WITH ONCE-MONTHLY PALIPERIDONE PALMITATE IN ACUTE AND IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    Bjorner, A.
    Knegtering, R.
    Parellada, E.
    Carpiniello, B.
    Vidailhet, P.
    Mertens, C.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [36] Impact of once-monthly paliperidone palmitate treatment on hospitalisation risk in patients with schizophrenia switching from oral antipsychotics
    Li, N.
    Zhuo, J.
    Tan, W.
    Turkoz, I.
    Mathews, M.
    Feng, Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S941 - S941
  • [37] A Pragmatic Analysis Comparing Once-monthly Paliperidone Palmitate Versus Daily Oral Antipsychotic Treatment in Patients with Schizophrenia
    Alphs, Larry
    Benson, Carmela
    Bossie, Cynthia
    Mao, Lian
    Starr, H. Lynn
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S364 - S365
  • [38] Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia
    El Khoury, Antoine C.
    Patel, Charmi
    Mavros, Panagiotis
    Huang, Ahong
    Wang, Li
    Bashyal, Richa
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 3159 - 3170
  • [39] Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Sliwa, Jennifer Kern
    Ma, Yi-Wen
    Alphs, Larry
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2011, 1 (04) : 111 - 124
  • [40] Aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by age: Results from QUALIFY, a head-to-head study
    Naber, D.
    Hansen, K.
    Forray, C.
    Baker, R. A.
    Sapin, C.
    Beillat, M.
    Peters-Strickland, T.
    Nylander, A.
    Hertel, P.
    Andersen, H. Steen
    Eramo, A.
    Loze, J.
    Potkin, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S527 - S528
12345